Shivani Nyati, the head of wealth at Swastika Investmart Ltd, remarked that Indegene, a provider of digital-led commercialization services for the life sciences industry, had defied market negativity with a spectacular debut on the stock exchanges. She noted that the company’s shares were listed at an impressive Rs. 655 per share, representing a remarkable 45% gain over its issue price of Rs. 452. This strong performance was attributed to a significant investor response, with the IPO receiving an overwhelming 70 times subscription. She also mentioned that Indegene had a well-established presence in the life sciences sector, serving leading biopharmaceutical companies and demonstrating consistent growth. Additionally, she highlighted that the company’s robust technology portfolio and focus on digital-led services positioned it well for future success in a rapidly evolving market.
